204 related articles for article (PubMed ID: 23237122)
1. Incidence of cytological abnormalities within 24 months of a normal cervical smear in Soweto, South Africa.
Adam Y; McIntyre JA; De Bruyn G
S Afr Med J; 2012 Nov; 103(1):34-9. PubMed ID: 23237122
[TBL] [Abstract][Full Text] [Related]
2. Assessing national cervical cancer screening guidelines: Results from an HIV testing clinic also screening for cervical cancer and HPV in Soweto, South Africa.
Hopkins KL; Jaffer M; Hlongwane KE; Otwombe K; Dietrich J; Cheyip M; Olivier J; Doherty T; Gray GE
PLoS One; 2021; 16(7):e0255124. PubMed ID: 34329334
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus (HPV) infections as risk factors for cytological and histological abnormalities in baseline PAP smear-negative women followed-up for 2 years in the LAMS study.
Gontijo RC; Derchain SF; Roteli-Martins C; Bragança JF; Sarian LO; Morais SS; Maeda MY; Longatto-Filho A; Syrjänen KJ
Eur J Obstet Gynecol Reprod Biol; 2007 Aug; 133(2):239-46. PubMed ID: 16814450
[TBL] [Abstract][Full Text] [Related]
4. Safety of screening with Human papillomavirus testing for cervical cancer at three-year intervals in a high-risk population: experience from the LAMS study.
Derchain SF; Sarian LO; Naud P; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Serpa-Hammes L; Matos J; Gontijo RC; Bragança JF; Lima TP; Maeda MY; Lörincz A; Dores GB; Costa S; Syrjänen S; Syrjänen K
J Med Screen; 2008; 15(2):97-104. PubMed ID: 18573778
[TBL] [Abstract][Full Text] [Related]
5. The prevalence and course of preinvasive cervical lesions during pregnancy in a Northern Nigerian Teaching Hospital.
Bakari F; Abdul MA; Ahmed SA
Ann Afr Med; 2017; 16(2):74-80. PubMed ID: 28469121
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of abnormal cervical cytology by liquid based cytology in the antenatal care clinic, Thammasat University Hospital.
Khaengkhor P; Mairaing K; Suwannarurk K; Thaweekul Y; Poomtavorn Y; Pattaraarchachai J; Bhamarapravatana K
J Med Assoc Thai; 2011 Feb; 94(2):152-8. PubMed ID: 21534360
[TBL] [Abstract][Full Text] [Related]
7. High-grade cervical abnormalities and cervical cancer in women following a negative Pap smear with and without an endocervical component: a cohort study with 10 years of follow-up.
Sultana F; English DR; Simpson JA; Canfell K; Gertig DM; Saville M
Int J Cancer; 2014 Sep; 135(5):1213-9. PubMed ID: 24488882
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and Risk Assessment of Cervical Cancer Screening by Papanicolaou Smear and Visual Inspection with Acetic Acid for Pregnant Women at a Thai Provincial Hospital.
Lertcharernrit J; Sananpanichkul P; Suknikhom W; Bhamarapravatana K; Suwannarurk K; Leaungsomnapa Y
Asian Pac J Cancer Prev; 2016; 17(8):4163-7. PubMed ID: 27644678
[TBL] [Abstract][Full Text] [Related]
9. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
Manos MM; Kinney WK; Hurley LB; Sherman ME; Shieh-Ngai J; Kurman RJ; Ransley JE; Fetterman BJ; Hartinger JS; McIntosh KM; Pawlick GF; Hiatt RA
JAMA; 1999 May; 281(17):1605-10. PubMed ID: 10235153
[TBL] [Abstract][Full Text] [Related]
10. Liquid-based cytology versus conventional Papanicolaou smear in an organized screening program : a prospective randomized study.
Strander B; Andersson-Ellström A; Milsom I; Rådberg T; Ryd W
Cancer; 2007 Oct; 111(5):285-91. PubMed ID: 17724676
[TBL] [Abstract][Full Text] [Related]
11. Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening.
Guo M; Khanna A; Wang J; Dawlett MA; Kologinczak TL; Lyons GR; Bassett RL; Sneige N; Gong Y; Bevers TB
Cancer Cytopathol; 2017 Aug; 125(8):644-651. PubMed ID: 28498639
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic.
Ciotti M; Sesti F; Paba P; Benedetto A; Patrizi L; Criscuolo A; Piccione E; Branca M; Syrjänen K; Favalli C
Eur J Gynaecol Oncol; 2004; 25(5):577-84. PubMed ID: 15493169
[TBL] [Abstract][Full Text] [Related]
13. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance, after six months delay: a three-year experience in an Iranian university hospital.
Yarandi F; Shojaei H; Eftekhar Z; Izadi-Mood N
Aust N Z J Obstet Gynaecol; 2009 Apr; 49(2):207-10. PubMed ID: 19432613
[TBL] [Abstract][Full Text] [Related]
14. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
Gilham C; Sargent A; Kitchener HC; Peto J
Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
[TBL] [Abstract][Full Text] [Related]
15. Mapping the cervical cancer screening cascade among women living with HIV in Johannesburg, South Africa
Rohner E; Mulongo M; Pasipamire T; Oberlin AM; Goeieman B; Williams S; Lubeya MK; Rahangdale L; Chibwesha CJ
Int J Gynaecol Obstet; 2021 Jan; 152(1):53-59. PubMed ID: 33188707
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of high-risk human papillomavirus (HR-HPV) types 16 and 18 in healthy women with cytologically negative Pap smear.
Arora R; Kumar A; Prusty BK; Kailash U; Batra S; Das BC
Eur J Obstet Gynecol Reprod Biol; 2005 Jul; 121(1):104-9. PubMed ID: 15950365
[TBL] [Abstract][Full Text] [Related]
17. Quality control of cervical cytology using a 3-type HPV mRNA test increases screening program sensitivity of cervical intraepithelial neoplasia grade 2+ in young Norwegian women-A cohort study.
Westre B; Giske A; Guttormsen H; Wergeland Sørbye S; Skjeldestad FE
PLoS One; 2019; 14(11):e0221546. PubMed ID: 31689301
[TBL] [Abstract][Full Text] [Related]
18. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
19. Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice.
Katki HA; Kinney WK; Fetterman B; Lorey T; Poitras NE; Cheung L; Demuth F; Schiffman M; Wacholder S; Castle PE
Lancet Oncol; 2011 Jul; 12(7):663-72. PubMed ID: 21684207
[TBL] [Abstract][Full Text] [Related]
20. Incidence of cervical intraepithelial neoplasia grade III, and cancer of the cervix uteri following a negative Pap-smear in an opportunistic screening.
Gram IT; Macaluso M; Stalsberg H
Acta Obstet Gynecol Scand; 1998 Feb; 77(2):228-32. PubMed ID: 9512333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
